Key result
Myocardial injury during index hospitalization for COVID-19 was associated with 33.2% mortality at 12 months, compared to 4.9% with low-level and 0% with undetectable troponin.
Why the study?
Myocardial injury in COVID-19 increases in-hospital mortality, but its relationship to long-term sequelae of SARS-CoV-2 was unknown.
Does myocardial injury predict long-term mortality and postacute sequelae in patients hospitalized with COVID-19?
Cohort (n=483)
No
Does myocardial injury predict long-term mortality and postacute sequelae in patients hospitalized with COVID-19?
Absolute Event Rate: 33.2% vs 4.9%
Myocardial injury during index hospitalization for COVID-19 is associated with significantly increased short- and long-term mortality, though incremental mortality after surviving the index hospitalization is low.
Cardiac injury by hs-cTnT during COVID-19 hospitalization identifies high 12-month mortality; leaves open whether troponin-guided strategies alter outcomes.
Background Myocardial injury in patients with COVID-19 is associated with increased mortality during index hospitalization; however, the relationship to long-term sequelae of SARS-CoV-2 is unknown. This study assessed the relationship between myocardial injury (high-sensitivity cardiac troponin T level) during index hospitalization for COVID-19 and longer-term outcomes. Methods and Results This is a prospective cohort of patients who were hospitalized at a single center between March and May 2020 with SARS-CoV-2. Cardiac biomarkers were systematically collected. Outcomes were adjudicated and stratified on the basis of myocardial injury. The study cohort includes 483 patients who had high-sensitivity cardiac troponin T data during their index hospitalization. During index hospitalization, 91 (18.8%) died, 70 (14.4%) had thrombotic complications, and 126 (25.6%) had cardiovascular complications. By 12 months, 107 (22.2%) died. During index hospitalization, 301 (62.3%) had cardiac injury (high-sensitivity cardiac troponin T≧14 ng/L); these patients had 28.6%, 32.2%, and 33.2% mortality during index hospitalization, at 6 months, and at 12 months, respectively, compared with 4.1%, 4.9%, and 4.9% mortality for those with low-level positive troponin and 0%, 0%, and 0% for those with undetectable troponin. Of 392 (81.2%) patients who survived the index hospitalization, 94 (24%) had at least 1 readmission within 12 months, of whom 61 (65%) had myocardial injury during the index hospitalization. Of 377 (96%) patients who were alive and had follow-up after the index hospitalization, 211 (56%) patients had a documented, detailed clinical assessment at 6 months. A total of 78 of 211 (37.0%) had ongoing COVID-19-related symptoms; 34 of 211 (16.1%) had neurocognitive decline, 8 of 211 (3.8%) had increased supplemental oxygen requirements, and 42 of 211 (19.9%) had worsening functional status. Conclusions Myocardial injury during index hospitalization for COVID-19 was associated with increased mortality and may predict who are more likely to have postacute sequelae of COVID-19. Among patients who survived their index hospitalization, the incremental mortality through 12 months was low, even among troponin-positive patients.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a cohort in COVID-19 (n=483). Myocardial injury (high-sensitivity cardiac troponin T ≧14 ng/L) vs. Low-level positive or undetectable troponin was evaluated on Mortality at 12 months. Myocardial injury during index hospitalization for COVID-19 was associated with 33.2% mortality at 12 months, compared to 4.9% with low-level and 0% with undetectable troponin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: